Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07135596 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of OviTex® PRS in Breast Reconstruction
A NA study, sponsored by Tela Bio.
- Recruiting
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT07135596 is a NA study that is actively recruiting participants, run by Tela Bio. The registered enrollment target is 235 participants.
The verdict
NCT07135596, a NA study, is actively recruiting participants, sponsored by Tela Bio.
- RECRUITING
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.
Interventions
- DEVICE OviTex PRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2026-04-10 |
| Est. Completion | 2034-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07135596
The ClinicalTrials.gov registry entry for NCT07135596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tela Bio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OviTex PRS is the first listed.
NCT07135596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07135596 about?
NCT07135596 is a clinical study titled "Effectiveness and Safety of OviTex® PRS in Breast Reconstruction". The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.
What is the current status of trial NCT07135596?
This trial is currently recruiting. It is a NA study. The enrollment target is 235 participants. The study started on 2026-04-10. Estimated completion is 2034-06.
What interventions are being tested in trial NCT07135596?
The interventions under investigation include: OviTex PRS (DEVICE).
Who is sponsoring clinical trial NCT07135596?
This trial is sponsored by Tela Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.